Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network
Jan Hillert, Tim Spelman(Peter Doherty Institute), María Trojano(University of Bari Aldo Moro), Sandra Vukusic(Institut NeuroMyoGène), Helmut Butzkueven(Monash Alfred Psychiatry Research centre), Pietro Iaffaldano(University of Bari Aldo Moro), Robert Hyde(Biogen (Switzerland)), Per Soelberg Sørensen(University of Copenhagen), Fabio Pellegrini(Biogen (Switzerland)), Ali Manouchehrinia(Karolinska Institutet), Melinda Magyari(University of Copenhagen), Anneke Van Der Welt, Leszek Stawiarz(Karolinska Institutet)
Cited by 41
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k